Gallium-Doped Hydroxyapatite Shows Antibacterial Activity against
antibacterial properties
biocompatibility
calcium phosphate
gallium
Journal
Journal of functional biomaterials
ISSN: 2079-4983
Titre abrégé: J Funct Biomater
Pays: Switzerland
ID NLM: 101570734
Informations de publication
Date de publication:
17 Jan 2023
17 Jan 2023
Historique:
received:
15
12
2022
revised:
04
01
2023
accepted:
11
01
2023
entrez:
24
2
2023
pubmed:
25
2
2023
medline:
25
2
2023
Statut:
epublish
Résumé
Calcium phosphates (CaPs) have been used in bone regeneration for decades. Among the described CaPs, synthetic hydroxyapatite (HAp) has a chemical composition similar to that of natural bone. Gallium-containing compounds have been studied since the 1970s for the treatment of autoimmune diseases and have shown beneficial properties, such as antibacterial activity and inhibition of osteoclast activity. In this study, we synthesized hydroxyapatite (HAp) powder with Ga doping ratios up to 6.9 ± 0.5 wt% using the wet chemical precipitation method. The obtained products were characterized using XRD, BET, FTIR, and ICP-MS. Ga
Identifiants
pubmed: 36826850
pii: jfb14020051
doi: 10.3390/jfb14020051
pmc: PMC9961062
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Oral Maxillofac Surg. 2017 Jun;75(6):1274.e1-1274.e10
pubmed: 28219630
Curr Opin Pharmacol. 2013 Oct;13(5):707-16
pubmed: 23876838
Nanoscale Res Lett. 2021 Apr 26;16(1):67
pubmed: 33900483
Biomatter. 2012 Oct-Dec;2(4):176-94
pubmed: 23507884
J Biomed Mater Res A. 2018 Feb;106(2):521-530
pubmed: 28960765
Acta Biomater. 2020 Nov;117:21-39
pubmed: 33007487
Inorg Chem. 2020 May 4;59(9):6242-6254
pubmed: 32286066
J Biomed Mater Res A. 2005 Dec 1;75(3):541-55
pubmed: 16108034
J Biomed Mater Res A. 2009 May;89(2):326-35
pubmed: 18431794
J Periodontol. 1984 Jul;55(7):406-9
pubmed: 6086869
Biomaterials. 2006 Apr;27(11):2331-9
pubmed: 16364434
Nat Rev Microbiol. 2013 Jun;11(6):371-84
pubmed: 23669886
Cold Spring Harb Perspect Biol. 2010 May;2(5):a000414
pubmed: 20452953
J Clin Invest. 2007 Apr;117(4):877-88
pubmed: 17364024
Int J Nanomedicine. 2017 Feb 14;12:1227-1249
pubmed: 28243086
Antimicrob Agents Chemother. 2011 Dec;55(12):5568-80
pubmed: 21947396
Biomedicines. 2022 Mar 22;10(4):
pubmed: 35453486
Int J Mol Sci. 2021 Mar 10;22(6):
pubmed: 33802163
J R Soc Interface. 2012 Mar 7;9(68):401-19
pubmed: 22158843
ACS Omega. 2020 Oct 16;5(42):27204-27210
pubmed: 33134681
J Prosthet Dent. 1979 Nov;42(5):551-6
pubmed: 290806
Acta Biomater. 2022 Sep 15;150:48-57
pubmed: 35933101
Int J Mol Sci. 2020 Jul 15;21(14):
pubmed: 32679901
Chin Med J (Engl). 2015 Apr 20;128(8):1121-7
pubmed: 25881610
Future Microbiol. 2014;9(3):379-97
pubmed: 24762310
Biomaterials. 1985 May;6(3):189-92
pubmed: 4005363
Materials (Basel). 2018 Oct 24;11(11):
pubmed: 30355975
Colloids Surf B Biointerfaces. 2009 Nov 1;74(1):91-5
pubmed: 19640688
J Prosthodont. 2006 Sep-Oct;15(5):321-8
pubmed: 16958734
Calcif Tissue Int. 1989 Aug;45(2):81-7
pubmed: 2550117
Acta Biomater. 2018 Aug;76:333-343
pubmed: 29966758
Biomater Res. 2019 Jan 14;23:4
pubmed: 30675377
J Inorg Biochem. 2021 Jan;214:111309
pubmed: 33212396
Angew Chem Int Ed Engl. 2013 Feb 4;52(6):1636-53
pubmed: 23255416
R Soc Open Sci. 2021 Jan 13;8(1):201785
pubmed: 33614097